Scientists have uncovered a troubling role for a vitamin A byproduct in cancer, which appears to help tumours slip past the ...
Mairs & Power Growth Fund trailed the S&P 500 in 2025 with a 10.54% return amid AI-driven market concentration. Review the ...
After J.P. Morgan, biotech’s bold promises meet real-world challenges. In 2026, success starts with a CDMO partner who ...
Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback